Methods For Generation Of Pluripotent and Multipotent Cells Read more about Methods For Generation Of Pluripotent and Multipotent Cells US Application 61/735,701Filed on 2012-12-11
TumIor-Specific GM-CSF Cytokine Response as Predictor of Cancer Vaccine Effectiveness Read more about TumIor-Specific GM-CSF Cytokine Response as Predictor of Cancer Vaccine Effectiveness US Application 61/569,131Filed on 2011-12-09
USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS Read more about USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS US Application 61/563,273Filed on 2011-11-23
High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof Read more about High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof US Application 61/654,232Filed on 2012-06-01
NIK Inhibitors That Selectively Target NIK-Dependent B-Cell Lymphoma Read more about NIK Inhibitors That Selectively Target NIK-Dependent B-Cell Lymphoma US Application 61/745,422Filed on 2012-12-21
EXPRESSION OF PROTEIN-CODING AND NONCODING GENES AS PROGNOSTIC CLASSIFIER IN EARLY STAGE LUNG CANCER Read more about EXPRESSION OF PROTEIN-CODING AND NONCODING GENES AS PROGNOSTIC CLASSIFIER IN EARLY STAGE LUNG CANCER US Application 61/691,118Filed on 2012-08-20
Nanoparticles With Enhanced Entry Into Cancer Cells Read more about Nanoparticles With Enhanced Entry Into Cancer Cells US Application 61/648,735Filed on 2012-05-18
Methods For Generation Of Pluripotent And Multipotent Cells Read more about Methods For Generation Of Pluripotent And Multipotent Cells US Application 61/621,994Filed on 2012-04-09
Murine Anti-NY-ESO-1 T Cell Receptors Read more about Murine Anti-NY-ESO-1 T Cell Receptors US Application 61/650,020Filed on 2012-05-22
Fas Agonists And Antagonists As T-Cell Differentiation Modulators Read more about Fas Agonists And Antagonists As T-Cell Differentiation Modulators US Application 61/623,733Filed on 2012-04-13